- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT02164786
Metabolomics Dynamics Study for Severe Patient
Modeling Metabolomic Dynamics Based on Nuclear Magnetic Resonance and High Performance Liquid Chromatography for Severe Patient: a Cohort Study
Acute severe disease is a major public health challenge that often affects young adults.In past decade, there are lot of new techniques have been developed that aim to improve the outcome of acute severe disease, But few of these works success. According to recently studies, the mortality of the multiple organ dysfunction syndrome(MODS) that is the major cause of death in patients who suffering from acute severe disease, is not improved. On the contrary, if MODS be predicted in early stage of acute severe disease, the death can be prevented. Because acute severe disease poses complex injury that involves multiple pathological processes, understanding the cellular and metabolic network malfunction during acute severe disease is crucial for clinical monitoring and intervention.
Human metabolism is a complex network with hundreds of cross-linked paths. During critical illness, the metabolic network is dynamically disturbed at multiple points. Classical research typically isolates a small part of this network to investigate the impact of pathological physiology molecular mechanisms on clinical outcome. In particular, researchers have examined metabolic disturbances such as cytokine network dysfunction, skeletal muscle breakdown, insulin resistance, dyslipidemia, testosterone and growth hormone/Insulin like growth factor (IGF)dysfunctions, low thyroxine syndrome, and deficiency of vitamin D and calcium with secondary hyperparathyroidism. These complex metabolic disturbances appear and interact at different stages during the pathological process after acute severe illness. Therefore, an integrated approach that combines the biochemical/molecular changes with network disturbances is the key to understanding acute severe illness at the systems biology level and establishing an accurate quantitative model for clinical monitoring.
An interdisciplinary method that includes high-throughput quantitative techniques and effective mathematical and visualization tools is necessary. Furthermore, interdisciplinary methods present the opportunity to develop innovative clinical diagnosis and monitoring methods for severe injuries. The aim of this study is to provide a novel high-throughput method that integrated proton-nuclear magnetic resonance (NMR) metabolomic fingerprinting and High Performance Liquid Chromatography with advance mathematics tools to modeling metabolic dynamics after acute severe disease.
Studieöversikt
Status
Studietyp
Inskrivning (Förväntat)
Kontakter och platser
Studieorter
-
-
Sichuan
-
Chengdu, Sichuan, Kina, 610072
- Rekrytering
- Sichuan Academy of Medical Sciences
-
Kontakt:
- Hua Jiang, MBBS,PhD
- Telefonnummer: 8613980001701
- E-post: cdjianghua@gmail.com
-
Kontakt:
- Bin Cai, MBBS
- Telefonnummer: 86-18981838125
- E-post: bin.cai@traumabank.org
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Beskrivning
Inclusion Criteria:
- Age:18-70 years
- Acute Physiology And Chronic Health Evaluation(APACHE)II>10
Exclusion Criteria:
- With comorbidity (Diabetes,Hyperthyroidism or primary organ dysfunction )
- Pregnancy
Studieplan
Hur är studien utformad?
Designdetaljer
Kohorter och interventioner
Grupp / Kohort |
|---|
|
Acute severe disease
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Tidsram |
|---|---|
|
Dödlighet vid sjukhusvistelse
Tidsram: Dödshändelser från inskrivning till utskrivning (upp till 10 veckor)
|
Dödshändelser från inskrivning till utskrivning (upp till 10 veckor)
|
Sekundära resultatmått
Resultatmått |
Tidsram |
|---|---|
|
Multi Organ Dysfunction Syndrome(MODS)
Tidsram: MODS events occurence from admission to discharge(up to 10 weeks)
|
MODS events occurence from admission to discharge(up to 10 weeks)
|
Samarbetspartners och utredare
Utredare
- Studiestol: Hua Jiang, PhD, MBBS, Sichuan Academy of Medical Sciences
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Förväntat)
Avslutad studie (Förväntat)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Andra studie-ID-nummer
- MetaLab_2014_001
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .